Reuters logo
BRIEF-SK Capital announces deal to acquire Perrigo Company plc’s active pharmaceutical ingredients business
2017年8月10日 / 下午4点15分 / 3 个月前

BRIEF-SK Capital announces deal to acquire Perrigo Company plc’s active pharmaceutical ingredients business

Aug 10 (Reuters) - SK Capital:

* SK Capital announces agreement to acquire Perrigo Company plc’s active pharmaceutical ingredients business

* SK Capital announces agreement to acquire Perrigo Company plc’s active pharmaceutical ingredients business​

* Parties have agreed to enter into long-term supply agreement for Perrigo API to supply multiple existing commercial, pipeline APIs to Perrigo

* Transaction is expected to close during Q4 2017, before which a new trade name will be selected and announced for business ​

* Four israeli pharmaceutical executives will be joining board of directors of Perrigo API in partnership with SK Capital​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below